Condition: AIS · Sponsor: CSPC-NBP Pharmaceutical Co., Ltd.
This is a Phase 2 multicenter, randomized, double-blind, placebo-controlled, add-on to standard of care study of NBP softgel capsules for the treatment of mild to moderate AIS in adults.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Investigative Site | Los Angeles, California, United States | — |
| Investigative Site | Los Angeles, California, United States | — |
| Investigative Site | Jacksonville, Florida, United States | — |
| Investigative Site | Des Moines, Iowa, United States | — |
| Investigative Site | Louisville, Kentucky, United States | — |
| Investigative Site | Boston, Massachusetts, United States | — |
| Investigative Site | Golden Valley, Minnesota, United States | — |
| Investigative Site | St Louis, Missouri, United States | — |
| Investigative Site | Omaha, Nebraska, United States | — |
| Investigative Site | Buffalo, New York, United States | — |
| Investigative Site | Asheville, North Carolina, United States | — |
| Investigative Site | Columbus, Ohio, United States | — |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02905565